Prelude Therapeutics

PRLD • NASDAQ • Stock Fundamentals

Prelude Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Krishna Vaddi, with a market cap of $325.7M.

Market Cap$325.7M

Employees128.0

CEOKrishna Vaddi

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Prelude Therapeutics

Prelude Therapeutics (PRLD) has a market capitalization of $325.7M and trades on NASDAQ.

Prelude Therapeutics has approximately 128 employees.